Literature DB >> 15173005

Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes.

Marlene R D Quadros1, Francesca Peruzzi, Csaba Kari, Ulrich Rodeck.   

Abstract

Previous work implicated activation of the signal transducer and activator of transcription (STAT)3 downstream of the epidermal growth factor receptor (EGFR) in the malignant phenotype of squamous carcinoma cells (SCC). Here, we show that EGFR-dependent STAT3 activation is restricted to malignant keratinocytes. Specifically, constitutive and epidermal growth factor-induced phosphorylation of STAT3 on Y705 was observed only in SCC but not in either immortalized (HaCaT) or normal keratinocyte strains. Furthermore, STAT3 activation as determined by DNA binding assays was restricted to SCC and dependent on EGFR activation. Forced expression of EGFR in immortalized keratinocytes (HaCaT cells) was associated with enhanced EGFR activation but not STAT3-Y705 phosphorylation. EGFR-dependent activation of mitogen-activated protein kinase (MAPK) kinase 1 negatively regulated STAT3-Y705 phosphorylation in normal and malignant keratinocytes. Together, these results underscore that EGFR activation is required but not sufficient for STAT3 activation to occur in malignant keratinocytes. They also highlight complex regulation of STAT3 phosphorylation through EGFR activation including negative regulation via the MAPK kinase/MAPK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173005     DOI: 10.1158/0008-5472.CAN-04-0214

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Keratinocyte apoptosis in epidermal development and disease.

Authors:  Deepak Raj; Douglas E Brash; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

2.  Gene expression profiles as markers of aggressive disease-EGFR as a factor.

Authors:  Christine H Chung; Joel Parker; Shawn Levy; Robbert J Slebos; Adam P Dicker; Ulrich Rodeck
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

3.  Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

Authors:  Weijie Li; Christine Marshall; Lijuan Mei; Joel Gelfand; John T Seykora
Journal:  J Biol Chem       Date:  2006-10-16       Impact factor: 5.157

4.  Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.

Authors:  Cristiane H Squarize; Rogerio M Castilho; Virote Sriuranpong; Decio S Pinto; Jorge Silvio Gutkind
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

5.  JNK1/2 expression and modulation of STAT3 signaling in oral cancer.

Authors:  Ioannis Gkouveris; Nikolaos Nikitakis; Maria Karanikou; George Rassidakis; Alexandra Sklavounou
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

6.  Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.

Authors:  Nikki Cheng; Anna Chytil; Yu Shyr; Alison Joly; Harold L Moses
Journal:  Mol Cancer Res       Date:  2008-10       Impact factor: 5.852

7.  Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.

Authors:  Juliana Xu; Renia Sylvester; Ann P Tighe; Siming Chen; Lorraine J Gudas
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

8.  STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells.

Authors:  Akiko Onishi; Qianming Chen; Joseph O Humtsoe; Randall H Kramer
Journal:  Exp Cell Res       Date:  2007-09-29       Impact factor: 3.905

9.  Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.

Authors:  Banibrata Sen; Babita Saigal; Nila Parikh; Gary Gallick; Faye M Johnson
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients.

Authors:  Kazuhiro Yamamoto; Kazuaki Shinomiya; Takeshi Ioroi; Sachi Hirata; Kenichi Harada; Manabu Suno; Tatsuya Nishioka; Manabu Kume; Hiroo Makimoto; Tsutomu Nakagawa; Takeshi Hirano; Toshinori Bito; Chikako Nishigori; Hideaki Miyake; Masato Fujisawa; Midori Hirai
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.